Skip to content
As weakening investment plagues small, innovative biotechs on both sides of the Atlantic, one bright spot in providing funding is acquisitions—though even that vital […]
M&A activity a bright spot in funding for biotech, expert tells 2023 BIO-Europe Read More »
Cardiovascular disease (CVD) is the leading cause of death worldwide and is responsible for over 900,000 deaths in the U.S. annually—and hypercholesterolemia, or elevated
A promising oral pill for ‘bad cholesterol’ is exciting news for heart patients Read More »
Remarks from Dr. Ted W. Love, Chairman of the Biotechnology Innovation Organization (BIO) and former President and CEO of Global Blood Therapeutics, as prepared
Dr. Ted W. Love: How to reframe the narrative about biotech – and put patients first Read More »
Amgen Inc., an Advocate level sponsor of the 2023 BIO Patient & Health Advocacy Summit, provided their approval to share this previously published article
The U.S. Food and Drug Administration (FDA) has approved TIBSOVO (ivosidenib) as a treatment for a rare blood cancer, the agency said in an
Rare blood cancer drug wins FDA approval Read More »
Dr. Mary-Ann Etiebet, Associate Vice President, Health Equity, Merck, has more than two decades of experience working across the public and private sectors to
Turning insights into action: building a U.S. health system that delivers for all women Read More »
Blood clots are commonly missed. According to the National Blood Clot Alliance (NBCA), “fewer than 1 in 4 people have any recognition of blood
A new class of medicines provides hope for patients at risk of dangerous blood clots Read More »
Patients’ stories are powerful—especially when it comes to advocacy, agreed panelists at the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit. An October
Patients are your best advocates – here’s how to support them Read More »
Sepsis is the third most common cause of disease-related death in the United States. Bacterial infections are the most common cause of sepsis. But
How COVID-19 is increasing incidence of another life-threatening condition Read More »
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during
How to protect patient access to Medicaid Read More »
